These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18940676)

  • 1. HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection.
    Onozawa M; Hashino S; Darmanin S; Okada K; Morita R; Takahata M; Shigematsu A; Kahata K; Kondo T; Tanaka J; Imamura M; Asaka M
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1226-30. PubMed ID: 18940676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A; Boehm S; Hahn J; Holler E; Jilg W
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
    Hammond SP; Borchelt AM; Ukomadu C; Ho VT; Baden LR; Marty FM
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1049-59. PubMed ID: 19660717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.
    Hsiao LT; Chiou TJ; Liu JH; Chu CJ; Lin YC; Chao TC; Wang WS; Yen CC; Yang MH; Tzeng CH; Chen PM
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):84-94. PubMed ID: 16399572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation.
    Knöll A; Boehm S; Hahn J; Holler E; Jilg W
    Bone Marrow Transplant; 2004 May; 33(9):925-9. PubMed ID: 15004543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].
    Fujimaki K; Nakaseko C; Oshima K; Sakai M; Chou R; Kanda Y; Nishimura M; Kanamori H; Sakamaki H
    Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
    Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
    Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
    Locasciulli A; Bruno B; Alessandrino EP; Meloni G; Arcese W; Bandini G; Cassibba V; Rotoli B; Morra E; Majolino I; Alberti A; Bacigalupo A;
    Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of hepatitis B virus infection on the outcome of hematopoietic stem cell transplantation].
    Du H; Wang M; Yang DL; Huang Y; Han MZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Apr; 29(4):387-91. PubMed ID: 18844000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease.
    Seth P; Alrajhi AA; Kagevi I; Chaudhary MA; Colcol E; Sahovic E; Aljurf M; Gyger M
    Bone Marrow Transplant; 2002 Aug; 30(3):189-94. PubMed ID: 12189538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
    Kaloyannidis P; Batsis I; Yannaki E; Adamidou D; Bartzoudis D; Papathanasiou M; Mallouri D; Sakellari I; Fassas A; Anagnostopoulos A
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1049-56. PubMed ID: 17697967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
    Cerva C; Colagrossi L; Maffongelli G; Salpini R; Di Carlo D; Malagnino V; Battisti A; Ricciardi A; Pollicita M; Bianchi A; Picardi A; Cudillo L; Cerretti R; De Angelis G; Cantonetti M; Andreoni M; Perno CF; Arcese W; Svicher V; Sarmati L
    Clin Microbiol Infect; 2016 Nov; 22(11):946.e1-946.e8. PubMed ID: 27475741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of humoral and cellular hepatitis B immunity by allogeneic hematopoietic cell transplantation.
    Lindemann M; Barsegian V; Runde V; Fiedler M; Heermann KH; Schaefer UW; Roggendorf M; Grosse-Wilde H
    Transplantation; 2003 Mar; 75(6):833-8. PubMed ID: 12660511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: a pediatric experience.
    Faraci M; Cappelli B; Lanino E; Morreale G; Fioredda F; Giudice CL; Giacchino R
    Pediatr Transplant; 2009 Nov; 13(7):923-6. PubMed ID: 19032422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The impact of hepatitis B virus infected patients or donors on the outcome of hematopoietic stem cell transplantation].
    Feng S; Han M; Zhang L; Li C; Qiu L; Li H; Wang Z; Jiang R; Yan W; Han Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):414-6. PubMed ID: 11877014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of de novo hepatitis B infection in liver allograft recipients with previous hepatitis B infection or hepatitis B vaccination.
    Bárcena Marugán R; García-Hoz F; Vázquez Romero M; Nash R; Mateos M; González Alonso R; García González M; García Plaza A
    Am J Gastroenterol; 2002 Sep; 97(9):2398-401. PubMed ID: 12358263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation.
    Hui CK; Yu J; Au WY; Zhang HY; Bartholomeusz A; Locarnini S; Kwong YL; Liang R; Lau GK
    J Clin Virol; 2005 Feb; 32(2):173-8. PubMed ID: 15653422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of hepatitis B virus serologic status after allogeneic hematopoietic stem cell transplantation and impact of donor immunity on hepatitis B virus.
    Park S; Kim K; Kim DH; Jang JH; Kim SJ; Kim WS; Jung CW; Koh KC
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1630-7. PubMed ID: 21565276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.